HuGE Literature Finder
Records
1
-
3
| Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
| Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Apr . Wang Yuzhuo, Gorlova Olga Y, Gorlov Ivan P, Zhu Meng, Dai Juncheng, Albanes Demetrius, Lam Stephen, Tardon Adonina, Chen Chu, Goodman Gary E, Bojesen Stig E, Landi Maria Teresa, Johansson Mattias, Risch Angela, Wichmann Heunz-Erich, Bickeböller Heike, Christiani David C, Rennert Gad, Arnold Susanne M, Brennan Paul, Field John K, Shete Sanjay, Le Marchand Loic, Melander Olle, Brunnström Hans, Liu Geoffrey, Hung Rayjean J, Andrew Angeline S, Kiemeney Lambertus A, Zienolddiny Shanbeh, Grankvist Kjell, Johansson Mikael, Caporaso Neil E, Woll Penella J, Lazarus Philip, Schabath Matthew B, Aldrich Melinda C, Stevens Victoria L, Ma Hongxia, Jin Guangfu, Hu Zhibin, Amos Christopher I, Shen Hongbi |
| Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular cancer 2010 9 (1): 188. Zhang Xuchao, Zhang Shirley, Yang Xuening, Yang Jinji, Zhou Qing, Yin Lucy, An Shejuan, Lin Jiaying, Chen Shiliang, Xie Zhi, Zhu Mike, Zhang Xiaolin, Wu Yi-lo |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 03, 2022
- Content source: